Radcliffe Capital Management’s AEON Biopharma AEON Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-12,404
| Closed | -$8.98M | – | 691 |
|
|
2022
Q4 | $8.98M | Hold |
12,404
| – | – | 0.28% | 66 |
|
|
2022
Q3 | $8.8M | Buy |
12,404
+369
| +3% | +$262K | 0.21% | 76 |
|
|
2022
Q2 | $8.5M | Hold |
12,035
| – | – | 0.2% | 78 |
|
|
2022
Q1 | $8.48M | Hold |
12,035
| – | – | 0.19% | 59 |
|
|
2021
Q4 | $8.42M | Hold |
12,035
| – | – | 0.22% | 51 |
|
|
2021
Q3 | $8.44M | Hold |
12,035
| – | – | 0.25% | 35 |
|
|
2021
Q2 | $8.35M | Buy |
+12,035
| New | +$8.35M | 0.26% | 22 |
|